E57-93660-37427
2 vaccinations
4 coded responses
17 check-ins
4 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 21-25
- ZIP prefix
- 995 / AK
- Registered
- 2020-12-19
- Relationship
- Self
- Race
- Multiracial
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-19
Registered in v-safe
-
2020-12-19
Dose 1 — Pfizer-BioNTech
-
2020-12-19
Health check-in — day 0, dose 1Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2020-12-20
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2020-12-21
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2020-12-22
-
2020-12-26
Survey response — day 7, dose 1MedDRA: Chest pain, Palpitations — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Chest pain, heart palpitations - experienced since 12/24MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2020-12-26
Report sent to call center — day 7, dose 1Be unable to do your normal daily activities1 call case(s)
-
2021-01-03
Survey response — day 14, dose 1MedDRA: Chest pain, Palpitations — Feeling: GoodFree text: Chest pain and palpitations with exertion (i.e during exercise and when lifting patients in my role as a hospital-based physical therapist. These symptoms began on 12/24. Symptoms persist > 1 hour after the activity with restMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-09
Dose 2 — Pfizer-BioNTech
-
2021-01-09
Health check-in — day 0, dose 2Feeling: Fair · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-01-10
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-01-15
-
2021-01-16
Health check-in — day 7, dose 2Feeling: Poor · Chills, Headache, Fatigue or tiredness, NauseaAdult check-in
- 2021-01-23
- 2021-02-06
- 2021-02-13
- 2021-02-20
- 2021-04-10
-
2021-07-12
Survey response — 6 months, dose 2MedDRA: Chills, Cough, Headache, Malaise, Pyrexia — Feeling: Poor · Be unable to do your normal daily activitiesFree text: Cough lasting the past 3 weeks, low grade fever, chills, malaise, headachesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2022-01-09
Survey response — 12 months, dose 2MedDRA: Nasopharyngitis, Oxygen saturation decreased, Tachycardia, Viral infection — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visitFree text: Viral infections, tachycardia and decreased oxygen saturation, cold symptomsMedDRA releases: 2024-11 · check-in free text available
-
2022-01-09
Report sent to call center — 12 months, dose 2Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
-
2022-01-11
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-19 | Pfizer-BioNTech | |
| 2 | 2021-01-09 | Pfizer-BioNTech |
Call center
2 call center cases
1 successful · 1 priority 2/3 (triaged and no follow up)
Free text
Release 1 — day 7, dose 1
Systemic reaction (other): Chest pain, heart palpitations - experienced since 12/24
Release 1 — day 14, dose 1
Symptoms: Chest pain and palpitations with exertion (i.e during exercise and when lifting patients in my role as a hospital-based physical therapist. These symptoms began on 12/24. Symptoms persist > 1 hour after the activity with rest
Release 9 — 6 months, dose 2
Symptoms: Cough lasting the past 3 weeks, low grade fever, chills, malaise, headaches
Release 10 — 12 months, dose 2
Symptoms: Viral infections, tachycardia and decreased oxygen saturation, cold symptoms
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Chest pain | ✓ | ✓ | ✓ |
| SD | Chills | ✓ | ✓ | ✓ |
| SD | Cough | ✓ | ✓ | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Malaise | ✓ | ✓ | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Oxygen saturation decreased | · | · | ✓ |
| SD | Palpitations | ✓ | ✓ | ✓ |
| SD | Pyrexia | ✓ | ✓ | ✓ |
| SD | Tachycardia | · | · | ✓ |
| SD | Viral infection | · | · | ✓ |
| SRO | Chest pain | ✓ | ✓ | ✓ |
| SRO | Palpitations | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release